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The recovery of animals from primary virus infections may be explained by 
several possible mechanisms.  These include both immune responses,  such as 
antibody and delayed hypersensitivity, and nonimmune mechanisms,  such as 
interferon, fever, and local changes in pH and oxygen tension. 
Recent evidence has permitted partial evaluation of the role of the immune 
responses. Irradiated guinea pigs in which no detectable neutralizing antibody 
could be demonstrated recovered from vaccinia virus infection as rapidly as 
did normal animals; the irradiated guinea pigs did, however, develop delayed 
hypersensitivity to vaccinia during recovery (1).  Chick embryos, 10 days or 
older, may recover from a variety of viral infections although they are unable 
to  produce  antibody but  are  able  to  produce  interferon  (2).  Human  hypo- 
gammaglobulinemics  usually recover from primary virus  infection despite  a 
very limited capacity to produce antibodies (3). 
Such findings  as  these have prompted suggestions  that  delayed hypersen- 
sitivity (4, 5) or interferon (6, 7), with or without other non-specific responses 
(8)  may be more important  than  antibody in  recovery from primary virus 
infections. Therefore, in order to evaluate the role of delayed hypersensitivity, 
guinea  pigs  were  treated  with  methotrexate  and  x-radiation  to  block  the 
delayed response (9), and recovery from vaccinia virus infection was observed. 
Results indicated that animals in which delayed hypersensitivity and antibody 
production were blocked,  but  capacity  to  produce  interferon preserved,  re- 
covered from vaccinia virus infection as rapidly as normal animals. 
Materials and Methods 
Animals.--Gulnea pigs were 200 to 300 gin Hartley albinos. 
Viruses,--Vaccinia virus was propagated in monolayer  cultures of guinea pig kidney tissue 
culture (GPK) maintained in medium 199 (10) or in the chorio-allantoic membrane of the 
embryonated chick egg and stored at -- 70°C. 
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Chiktmgunya virus (arborvirus group A, Mrican strain) obtained from Mr.  C.  ~. Gibbs, 
Laboratory of Tropical Virology, National Institutes of Health was propagated by intracere- 
bral passage in the newborn mouse. Encephalomyocarditis  (EMC) virus was an r mutant (11) 
prepared in mouse embryo fibroblast cultures. 
Infection  and Skin Testing.--Gninea  pigs were infected by intradermal inoculation of 0.1 
ml of a  10  -x dilution of vaccinia virus grown on the chick chorion. This consisted of 103a 50 
per cent guinea pig infectious doses. Animals were skin-tested by intradermal injection of 0.1 
ml from the virus pool grown in GPK. The skin test antigen had been heated to 60°C for 20 
minutes to inactivate the virus and then stored at 5°C. Reactions with erythema greater than 
10 mm in diameter at 24 to 48 hours after inoculation were considered positive. In no instance 
did a reaction occur before 18 hours after inoculation (1). 
Guinea Pig Heart  Cultures.--Guinea  pig heart  tissue cultures  (GPH)  were prepared by 
trypsinization of embryo or adult guinea pig hearts. These suspended cells were centrifuged at 
500 RP,~ and resuspended with 50 to 100 volumes of Earle's balanced salt solution at pH 7.8 
containing 0.5 per cent lactalbumin hydrolysate and 5 per cent calf serum. The resuspended 
cells were dispersed in 2 ml amounts into test tubes and propagated as stationary cultures at 
39°C. Confluent monolayers usually formed at 3 to 5 days. 
Antivaccinia Antibody Assays.--Serum or extracts of lesions were assayed for antibody to 
vaccinia virus in monkey kidney or HeLa cell tissue cultures by the highly sensitive plaque 
neutralization test (12). Results were expressed as percentage reduction in number of plaques 
as compared to controls. In some cases confirmatory tests were carried out using a pox count 
reduction test on the ehorio-allantoic membrane of the embryonated chick egg (13). 
Production and Assay of Guinea Pig Interferon.--Gninea  pig interferon was produced by 
infection of GPH tubes with 106 to 10  ~  plaque-forming  units (PFU) of Chikungunya virus (14). 
Supernatants were harvested 48 to 72 hours after infection. In order to destroy residual virus, 
it was treated in the presence of 1/100,000  thymol blue with 1 •  HCI until pH 2 was reached, 
transferred to a new flask,  and then brought back to neutrality with 1 N NaOH. Interferon 
was assayed by overnight incubation at 36°C of GPH tubes with 2 ml amounts of material to 
be assayed. The supernatants were then poured off and cultures challenged with 10 to 30 PFU 
of EMC virus in 2 ml of Eagle's basal medium containing 10 per cent skim milk (15). After 
incubation for 1 hour at 36°C a shell overlay (16) containing 0.1 per cent yeast extract, 0.1 per 
cent bovine serum albumin, 10 per cent skim milk, 1/50,000  neutral red and Earle's balanced 
salts was applied. A final reading of plaques was made on the first or second day  after over- 
laying. 
Guinea Pig Skin Suspensions.--Skin suspensions were prepared by finely mincing guinea 
pig skin specimens and then grinding the mince in a  mortar with sand. The mixtures were 
then diluted in Eagle's medium and 10 per cent skim milk and assayed as 10 per cent suspen- 
sions on chick chorio-aflantoic membranes for vaccinia virus content or spun in the ultra- 
centrifuge at 105,000 g for one-half hour, filtered through a Millipore HA filter, acid treated, 
assayed on GPH for interferon or on HeLa cells for antibody. 
Methotrexate Dose Sehedules.--Aminomethylpteroylglutamic  acid was purchased as metho- 
trexate from Lederle Laboratories Division of American Cyanamid Co.,  Pearl River, New 
York. Animals were injected intraperitoneaUy every 48 hours with 5 mg of methotrexate in 
one cc of Ringer's solution. Treatment was started 2 days before infection with vaccinia virus. 
X-Radiation.--Whole body x-radiation of 300 r  was administered to guinea pigs by Mr. 
Henry Meyer of the Radiation Branch of the National Cancer Institute. The dose was given 
over 2.43 minutes from a  250 kv source using simultaneous dorsal and ventral portals. The 
average observed mortality in animals receiving both methotrexate and radiation was 10 per 
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RESULTS 
Plan of Experiment.--Four guinea pigs were used in each group. In groups 
where methotrexate was employed, administration  of the drug was begun 48 
hours before the animals were infected with vaecinia virus.  In groups where 
animals  received x-radiation,  it  was  administered  24  hours  before infection. 
At intervals following infection groups of animals were skin-tested with heat- 
killed  vaccinia  virus  antigen  and  the  sites  read  after  6  and  24  hours.  The 
animals were then sacrificed by exsanguination and the site of infection excised. 
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FIG.  1.  Serum antivaccinia antibody response in control animals and in animals treated 
with methotrexate alone or in combination with 300 r total body x-radiation. 
The  sera  were  tested  for neutralizing antibody and  suspensions  were made 
from the skin. Aliquots of the latter were assayed for virus, for interferon, or 
for neutralizing antibody against vaccinia virus. 
Studies  on Antivaccinia Antibody in the Serum and at the Site of Infection.- 
The results of antibody studies on sera taken from experimental animals are 
shown in  Fig.  1.  In  control groups no significant neutralization of virus by 
serum was detected before 6 days, and in some experiments as late as 10 days 
following infection. Circulating antibody steadily increased in fiter after first 
appearing.  On  the other hand,  no significant neutralization of virus was  de- 
tected in the serums obtained throughout the experiment from animals treated 
with methotrexate alone or with both methotrexate and x-radiation. In addi- 350  RECOVERY  FRO~[  INFECTION  WITH  VACCINIA  VIRUS 
tion,  assay  of  undiluted  samples  of  20  per  cent  skin  extracts  from  lesions 
excised 1 or 2 days after infection failed to reveal the presence of local antibody 
in methotrexate- and x-radiation treated-animals. In previous studies no local 
antibody was present  at infection  sites of radiated  guinea pigs as  late as  10 
days after infection (1). 
Results  of Skin  Tests for  Delayed Hypersensitivity  to  Vaccinia  Virus.--The 
results of skin tests for delayed hypersensitivity to vaccinia virus are to be seen 
in  Table  I.  Untreated  controls  developed  delayed  reactions  on  the  5th  day 
following infection with vaccinia. 
TABLE  I 
Effect o/Methotrexate Alone or in Combination with 300 r x-radiation on the 
Devdopment of Dd~ ped Skin Reactions to Vavcinia Virus 
INumber of days after infection  with vaceinia virus when skin test 
Treatment  performed 
0  3  5  7  10  12  14  16 
None ...........................  0/4*  10/4}  4/4  ) 4/4 I 4/4  ] 4/4  I 4/4  I 4/4 
MethotrexateMeth°trexateSand  ...................  300 r total body  0/4  0/4  ND§  2/4  1/4  0/4  ND  1/4 
0/4  0/4  ND  0/4  ND  ] 0/4  0/3  0/3  x-radiation[[ ................... 
* Reported as positives over total tested. 
:~ Methotrexate given in 5 mg dose every 48 hours starting 2 days before infection. 
§ ND, skin tests not performed on these days. 
II Total body x-radiation administered 24 hours before infection. 
About 75 per cent of the animals treated with methotrexate alone failed to 
develop delayed skin hypersensitivity to vaccinia virus. There was no apparent 
difference in the recovery process of those animals which did become delayed 
sensitive to the infecting agent and those which did not. 
In the  case of the  groups treated with both methotrexate and x-radiation, 
however,  all  of  the  animals  failed  to  develop  delayed  reactions  to  vaccinia 
virus. By studying the course of the vaccinia infection in the immunologically 
blocked animals, the relative importance  of  the  immune  responses  could  be 
evaluated. 
Course of Vaccinia Infection in Treated and in Untreated Groups.--The course 
of the vaccinia infection was followed by viral titrations of lesion extracts.  It 
has  been previously demonstrated  that  virus  titers  remain  stable  in  the  in- 
fection site over a number of days and that elimination of virus had begun by 
the  8th  day  (1).  To  study  the  rate  of viral elimination,  lesion extracts were 
assayed from the  7th  to  the  14th  day following infection.  The course of the 
infections is shown in  Fig.  2,  taken from the results of one of several experi- ]~RIEDMAN~  BARON~  BUCKLER~  AND STEINMULLER  351 
ments. Untreated controls showed a decline in titer of virus obtained from the 
skin until no virus was found on the 12th day following the infection, indicating 
completion of  the recovery process.  Groups  of animals  treated  with metho- 
trexate alone or with methotrexate and radiation did not significantly differ 
from controls in  that  the  elimination  of detectable virus  from the  infection 
site in the skin was complete by two weeks after infection. 
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FzG. 2. "liter of vaccinia virus recovered from skin extracts of lesions in  control amLmaJs 
and in animals treated with methotrexate alone  or in  combination with 300  r  total  body 
x-radiation. Previous studies (1) demonstrated that virus Liters remain stable in the infection 
sites over a number of days (broken lines). 
The results  suggested  that recovery from primary infection may occur in 
the absence of delayed hypersensitivity and antibody. 
Studies on Infection Sites of Untreated Animals for Production  of Interferon.- 
Since interferon production has been associated with recovery from some virus 
infections (17-19), experiments were carried out to determine whether inter- 
feron was produced during vaccinia virus infection in the skin of guinea pigs. 
Vaccinia  lesion  extracts  from  untreated  guinea  pigs  were  acid-treated  and 
ultracentrifuged in order to eliminate residual virus. These extracts were then 
tested  on  GPH for their ability  to  inhibit  the growth  of EMC  virus.  As  is 
indicated in Table II,  1/60 dilutions of lesion extracts had greater inhibitory 
activity on EMC  virus plaque formation than  did interferon prepared from 
GPH.  On  the  other hand,  as  is  seen in  the  same  table,  skin  extracts from 
uninfected guinea pigs usually showed some enhancement of virus growth when 352  RECOVERY  FROM  INFECTION  WITH  VACCINIA  VIRUS 
compared with  diluent  controls.  In other  experiments  10  per  cent  extracts 
made from inflammatory lesions of guinea pig skin caused by turpentine  or by 
staphylococci had no virus inhibitory properties. 
Interferon Production in Infection Sites of Animals  Treated  With X-radiation 
and  Methotrexate.--As  may be seen on Table III, a  significant suppression  of 
EMC virus plaque formation was obtained  employing skin  extracts  from the 
TABLE II 
Suppression of EMC Virus Plaque Formation by Skin Extracts from the Site of 
Vaccinia Virus Infection in Guinea Pigs 
Preparation  Dilution  Number of  Decrease in 
plaques  plaques 
Diluent control 
Guinea pig heart interferon 
Uninfected guinea pig skin extracts 
Guinea pig skin extracts: 
48 hrs. after vaccinia infection 
96 hrs. after vaccinia infection 
1/5 
1/50 
1/60 
1/60 
1/60 
8,  10,  13 
1,  1,  4 
8,  11,  15 
17,  17,  19 
1,  3,  5 
6,  10,  15 
per cent 
80 
0 
82 
40 
TABLE III 
Suppression of EMC Virus Plaque Formation by Skin Extracts from Sites of 
Vaccinia Virus Infection in Guinea Pigs Treated with Radiation and 
M ethotr  exate 
Preparation 
Uninfected guinea pig skin 
Treated guinea pig skin: 
24 hrs. after vaccinia infection 
48 hrs. after vaccinia infection 
Dilution 
1/15 
1/lS 
1/15 
Number of 
plaques 
32,  42 
0,  5,  8 
14,  17 
Decrease in 
plaques 
per cent 
90 
58 
site  of vaccinia  virus  infection  in  guinea  pigs  treated  with  300  r  total  body 
x-radiation  and  methotrexate.  The  inhibitory  factor  appeared  as  early  as  1 
day after infection and was present on the 2nd day after infection. A  skin ex- 
tract from an uninfected animal  treated  with x-ray and methotrexate  had no 
virus inhibitory properties. 
Some of the properties of the skin extracts prepared from vaccinia infection 
sites in untreated  animals and in animals treated with x-radiation and metho- 
trexate  are  summarized  in  Table  IV.  Similar  to  the  reported  properties  of FRIEDMAN,  BARON,  BUCKLER~  AND  STEINMULLER  353 
interferon (20) the anfiviral activity of skin extracts was stable to acid (pH 2), 
to 60°C for 1 hour, and had activity in GPH tissue but not in chick embryo 
cells, the tissue of a heterologous species. Moreover, the antiviral activity was 
destroyed by boiling, and by trypsin, was not sedimented by 105,000 g for one- 
half hour and was non-specific with respect to virus. 
TABLE IV 
Properties of Interferon Extracted from Vaccinia Virus Infection Sites of 
Methotrexate and X-radiation  Treated and Untreated Guinea Pigs 
Treatment  Antiviral effect  following 
treatment 
pH2 ..................................................... 
60°C for 1 hr  .............................................. 
100°C for ~  hr  ........................................... 
Sedimentation, 105,000  g for 1~ hr  ........................... 
Trypsin, 0.2 mg/m| for 1 hr  ................................ 
Effect on: 
Chick embryo culture (heterologous  species)  ................ 
EMC virus (heterologous  virus) ......................... 
+ 
+ 
0 
+ 
0 
0 
+ 
+, preparation effective. 
0, preparation not effective. 
DISCUSSION 
The present study indicates that guinea pigs in which antibody production 
and delayed hypersensitivity were blocked recovered as well as normal animals 
from vaccinia virus  infection.  Interferon production was  present during  the 
course of the infection. 
These  results  are  consistent  with  the  hypothesis  that,  while  antibody is 
important in resistance to secondary viral infections, it is not essential to re- 
covery from primary viral infections  (1).  The finding  that  normal recovery 
occurred in the absence of delayed hypersensitivity suggests that the immune 
responses are not required for recovery from primary infections with vaccinia 
virus. 
In contrast to the findings in a  study of suppression of delayed hypersensi- 
tivity to soluble antigens by methotrexate alone (9), complete inhibition of the 
development  of  delayed  hypersensitivity  to  the  strong  antigenic  stimulus 
provided by a  replicating virus  required  treatment  with  both  methotrexate 
and  x-radiation.  That  treatment  with  x-radiation  and  methotrexate  in  the 
doses employed does not inhibit vaccinia infection in animals is indicated by 
the similarity of virus elimination in treated and in untreated groups (Fig. 2) 
and by the finding that methotrexate did not suppress vaccinia virus infection 
of rabbits  (21). In tissue cultures methotrexate did not inhibit the growth of 354  1LECOV'ERY  FROM  INFECTION  WITH  VACCINIA  VIRUS 
vaccinia virus, unless the cells had been made severely thymidine-deficient and 
even then the suppression was only partial (22). 
Additional evidence to support the view that delayed hypersensitivity is not 
essential  to  recovery comes from studies  of  the  ability  of  chick  embryos to 
recover from a variety of virus infections, although the chick embryo is immuno- 
logically immature  (2).  Guinea  pigs  which  had  been  made  delayed  hyper- 
sensitive  to vaccinia virus  did  not  manifest significantly enhanced  recovery 
over controls when both groups were infected with vaccinia virus (23). 
There has  been increasing  evidence that  recovery from primary virus  in- 
fections may be associated with non-immune mechanisms  such  as  interferon 
(6,  7),  elevated  temperature  (8),  changes  in  pH  (8),  and  decreased  oxygen 
tension  (16,  24,  25).  In  this  study  the  presence of interferon at  the  site  of 
infection  in  both  untreated  and  immunologically blocked  animals  confirms 
previous work which indicated that interferon was present in vaccinia lesions 
of rabbits (26) and is consistent with the concept that interferon is an important 
factor in  the recovery. Additional  evidence leading to this  hypothesis comes 
from the observation that  cell cultures may recover from vaccinia virus  in- 
fection; recovery was correlated with production of interferon (27). 
It seems reasonable that interferon which is active within the cell could be 
important in recovery from infections with viruses which spread directly from 
cell to  cell without being  exposed to  antibody  (e.g.  vaccinia, herpes simplex 
and varicelia viruses). There is some evidence that mediation of recovery by 
non-immune mechanisms may also take place in infections with viruses which 
spread through antibody-containing extracellular fluids.  Older chick embryos 
which  are  immunologically incompetent, but  which  can  produce  interferon, 
were found to recover from a variety of virus infections (2). Passive transfer of 
physiologic amounts  of antiviral antibody after the onset of virus infections 
generally fails to  alter  the  course of  the infection (5,  28,  29).  Hypogamma- 
globulinemic humans  recover normally from most virus infections despite  a 
markedly reduced capacity  to  produce  antibodies  (3).  In  mice  the  onset  of 
recovery from influenza pneumonia is  better  correlated with  interferon pro- 
duction than with antibody (17).  Inhibition or enhancement of the antiviral 
action  of  interferon  respectively  increases  or  decreases  mortality  in  mice 
infected with influenza virus (30). Taken together, this evidence indicates that 
the non-immune responses alone may be important even in the case of viruses 
which spread in extracellular fluids. 
SUMMARY 
In guinea pigs, methotrexate and x-radiation have been employed to block 
the development of delayed hypersensitivity and of antibody to vaccinia virus 
during experimental infection. 
Animals whose specific responses were blocked by x-radiation and  metho- FRIEDMAN~ BARON, BUCKLER, AND  STEIN~ULLER  355 
trexate  recovered  from  vaccinia  virus  infection  as  rapidly  as  non-treated 
control animals suggesting that these responses were not essential in recovery 
of the infected animals. 
A  virus-inhibiting  substance with  the properties of interferon was present 
in  skin  of  untreated  and  methotrexate-  and  x-radiation-treated  animals 
infected with vaccinia virus. 
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